Earn 15+ CPD credits while staying current with the latest advances.
Register 3+ colleagues and unlock 20% team discount.
Publish your findings in collaborated journals and receive exclusive discounts.
The International Conference on Cardiology and Cardiovascular Science held from March 26-28, 2026 is a prestigious global platform that brings together renowned cardiologists, cardiovascular surgeons, researchers, healthcare professionals, and industry experts to explore the latest breakthroughs in cardiovascular medicine. This hybrid event, available both in-person in Singapore and virtually, ensures global participation, allowing attendees to engage in insightful discussions, share research findings, and collaborate on advancing heart health.
The conference will feature cutting-edge keynote sessions from leading experts, presenting the latest developments in cardiac care, minimally invasive interventions, and innovative treatment strategies. Scientific sessions will cover a wide range of topics, including heart failure management, coronary artery disease, electrophysiology, cardiac imaging, and regenerative medicine. A key highlight of the conference is the interactive panel discussions, where experts will address pressing challenges such as cardiovascular risk factors, precision medicine, and the impact of lifestyle on heart health. Additionally, case study presentations will provide real-world insights into complex cardiac cases and emerging treatment modalities.
With ample opportunities for networking, collaboration, and knowledge sharing, CVS 2026 aims to bridge the gap between research and clinical practice, fostering innovative solutions to improve cardiovascular care worldwide. Whether attending in person or virtually, participants will benefit from a highly engaging and informative experience that contributes to the advancement of global heart health.
London Northwest University Healthcare NHS Trust, United Kingdom
The Mathews Journal of Cardiology is proud to serve as the supporting journal for this upcoming event on Cardiology and Cardiovascular Science. As part of this collaboration, a DOI will be assigned to the conference proceedings book, ensuring the research and findings presented at the event are globally accessible and citable. Additionally, participants who wish to publish their full-length research articles have the opportunity to submit their manuscripts for consideration in the Mathews Journal of Cardiology. This is an excellent platform for researchers and professionals to share their contributions to the field, receive peer-reviewed recognition, and enhance the visibility of their work. Article processing charges are completely...
Cardiology & Cardiovascular Science
At the forefront of leading Cardiology and Cardiovascular Science Conferences 2026, the global cardiovascular device market is valued at $74.7 billion (2025) and projected to exceed $148 billion by 2034 (CAGR 7.9%). The cardiac drug market follows at $157.8 billion, expanding steadily at 3.5%. These headline numbers set the agenda for Cardiology Conferences 2026 and beyond.
Looking toward Cardiology 2025, several macro-trends are accelerating investment and innovation:
Annual CVD spending already tops $400 billion in the U.S. and €210 billion in the EU. Supply-chain gaps, data-privacy rules and health-equity issues remain barriers often debated at major cardiology conferences.
North America leads revenue; Europe accelerates TAVR adoption; Asia-Pacific posts the fastest wearable uptake; LMICs scale community-screening programmes—core regional signals shaping our global cardiovascular science conference strategy.
| Segment | 2025 Value | 2030/34 Forecast | CAGR |
|---|---|---|---|
| Devices | $74.7 bn | $148 bn | 7.9% |
| Drugs | $157.8 bn | $214.9 bn | 3.5% |
| Monitoring | $8.2 bn | $13.2 bn | 8.2% |
| Wearables | $2.69 bn | >$5 bn | 11–12% |
| TAVR | $7.4 bn | $10.2 bn | 6.6% |
Gardens by the Bay
Marina Bay Sands
Merlion Park
Sentosa Island
Copyright 2024 Mathews International LLC All Rights Reserved
